K-Ras is the most frequently mutated oncogene in humans: more than 80% of pancreatic cancers and more than 30% of colorectal and cholangial cancers and lung adenocarcinomas harbour activating mutations of K-Ras gene as one of the founder carcinogenic mutation in the genome. Here, KRAS is linked to familial pancreatic carcinoma.